MedTrace Logo

Feasibility Study to Use Biosensing Devices to Monitor PA and Resp. Function in Smokers w and w/o Resp. Symptoms/COPD

NCT04081961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2020-03-03

Study results available
· View outcomes & findings →

Summary

This study examines the feasibility and acceptability of using mobile applications and biosensing (mHealth) devices in detecting vitality parameters in current smokers with and without respiratory symptoms/COPD (e.g., heart rate, blood oxygenation, steps/motion) for a future big-scale study.

Conditions

  • Signs and Symptoms, Respiratory
  • Mobile Applications
  • Activity Trackers
  • Respiratory Function Tests

Interventions

DEVICE

Anamed OEM device; Air Next mobile spirometry device

Anamed OEM (Original Equipment Manufacturer) device - physical activity and vital signs monitoring; Air Next mobile spirometry device

Sponsors & Collaborators

  • Philip Morris International

    collaborator INDUSTRY

  • Synergy Research Group

    collaborator INDUSTRY

  • Kazakhstan Academy of Preventive Medicine

    lead OTHER

Principal Investigators

  • Almaz Sharman, Dr · Kazakhstan Academy of Preventive Medicine

Eligibility

Min Age
40 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-07
Primary Completion
2019-10-10
Completion
2019-10-31

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04081961 on ClinicalTrials.gov